Cargando…
Cost-effectiveness evaluation of aspirin in primary prevention of myocardial infarction amongst males with average cardiovascular risk in Iran
Aspirin is one of the certified medicines commonly used for the secondary prevention of myocardial infarction (MI). Aspirin side effects and gastrointestinal bleeding, in particular, have arisen debates on its use for the primary prevention of MI. The present research evaluates the cost-effectivenes...
Autores principales: | Amirsadri, Mohammadreza, Sedighi, Mohammad Javad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385729/ https://www.ncbi.nlm.nih.gov/pubmed/28515767 http://dx.doi.org/10.4103/1735-5362.202453 |
Ejemplares similares
-
Cost-Effectiveness and Cost–Utility Analysis of the Use of Clopidogrel and Pantoprazole in Comparison with Clopidogrel and Omeprazole for the Secondary Prevention of Myocardial Infarction in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2021) -
Cost-effectiveness and cost-utility analysis of OTC use of simvastatin 10 mg for the primary prevention of myocardial infarction in Iranian men
por: Amirsadri, Mohammadreza, et al.
Publicado: (2015) -
154: A PHARMACOECONOMIC EVALUATION TO MAKE DECISION: IS THE USE OF SIMVASTATIN 10 MG AS AN OTC MEDICATION COST-EFFECTIVE FOR THE PRIMARY PREVENTION OF STROKE AMONGST WOMEN IN IRAN?
por: Amirsadri, Mohammadreza, et al.
Publicado: (2017) -
Cost-effectiveness and cost-utility analysis of type-2 diabetes screening in pharmacies in Iran
por: Amirsadri, Mohammadreza, et al.
Publicado: (2023) -
The influence of gender on the effects of aspirin in preventing myocardial infarction
por: Yerman, Todd, et al.
Publicado: (2007)